Financhill
Back

Regeneron Pharmaceuticals, Inc. Vs. Nebius Group NV Industry Stock Comparison

Buy
59

REGN
Regeneron Pharmaceuticals, Inc.

Last Price:
$767.87
Seasonality Move:
12.13%
Sell
42

NBIS
Nebius Group NV

Last Price:
$89.47
Seasonality Move:
-2.57%
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $767.96. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

  • The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals, Inc.'s stock price today?

  • The Regeneron Pharmaceuticals, Inc. share price today is $767.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

  • The Nebius Group NV share price today is $89.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 142.35 Buy
Relative Strength Index (14 RSI): 64.22 Buy
Chaikin Money Flow: 1264020 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (712.01 - 765.19) Buy
Bollinger Bands (100): (552.57 - 698.59) Buy

NBIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.05 Sell
Relative Strength Index (14 RSI): 47.32 Sell
Chaikin Money Flow: 13904832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.34 - 98.02) Sell
Bollinger Bands (100): (72.32 - 115.66) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 747.47 Buy
20-day SMA: 745.1 Buy
50-day SMA: 678.03 Buy
200-day SMA: 600.91 Buy
8-day EMA: 400.86 Buy
20-day EMA: 196.11 Buy
50-day EMA: 85.47 Buy
200-day EMA: 22.33 Buy

NBIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.08 Buy
20-day SMA: 91.37 Sell
50-day SMA: 102.98 Sell
200-day SMA: 65.21 Buy
8-day EMA: 85.42 Buy
20-day EMA: 90.53 Sell
50-day EMA: 95.55 Sell
200-day EMA: 73.6 Buy

Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.

Regeneron Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):